Background {#Sec1}
==========

With the prevalence of antimicrobial resistance (AMR), only a few antibiotics are available to treat severe infections caused by extensively drug-resistant (XDR) bacteria, which poses a great challenge to human health and food security. Tigecycline and colistin are last-resort drugs to treat infections caused by carbapenem-resistance *Enterobacteriaceae* \[[@CR1]\]. The World Health Organization (WHO) classified the two antibiotics as critically important antimicrobials, and their usage should be severely restricted ([[http://www.who.int/foodsafety/publications/antimicrobials-fifth/en/]{.ul}](http://www.who.int/foodsafety/publications/antimicrobials-fifth/en/)) \[[@CR2]\]. Since the recent reports of colistin resistance genes (*mcr*), the clinical application of colistin has become more limited \[[@CR2], [@CR3]\], turning tigecycline into the ultimate treatment option.

In May 2019, two tigecycline resistance genes, *tet*(X3) and *tet*(X4), were discovered, which can inactivate the entire family of tetracycline antibiotics, including tigecycline and the newly US FDA-approved drugs eravacycline and omadacycline \[[@CR4]\]. *Tet*(X3) and *tet*(X4) are the first plasmid-borne *tet*(X) genes, encoding proteins with 386 amino acids and 385 amino acids, respectively, and showing 85.1 and 94.3% identity, respectively, with the original *tet*(X) from *Bacterioides fragilis* \[[@CR4], [@CR5]\].

To date, both genes have been identified in humans, animals, meat, and environmental samples \[[@CR4], [@CR6]--[@CR8]\]. In three representative provinces of China, *tet*(X3) and *tet*(X4) genes have been identified in animals and meat for consumption at a high proportion of 43.3% \[[@CR4]\], indicating the wide transmission of tigecycline resistance. Recent studies showed that the presence of *tet*(X3) and *tet*(X4) genes can significantly increase the resistance to tigecycline, and the construction of a *tet*(X4)-containing bacterial strain, namely, *Escherichia coli* JM109 + pBAD24-tet(X4), increases the MIC value of tigecycline by 64-fold compared with the original host strain \[[@CR8]\].

Therefore, it is necessary to establish an efficient method for simultaneous screening the tigecycline-resistant genes *tet*(X3) and *tet*(X4) in different samples. Nowadays, real-time PCR assays are widely used in laboratories domestically and overseas. Compared to conventional PCR, real-time PCR has superior sensitivity, reproducibility, precision, and high throughput capability \[[@CR9]\]. In this study, we designed a rapid, sensitive TaqMan-based multiplex real-time PCR assay for the specific detection of the tigecycline resistance genes *tet*(X3) and *tet*(X4), and further evaluated using cultured bacteria, faeces and soil samples.

Results {#Sec2}
=======

Primers and probes {#Sec3}
------------------

The results of the NCBI Primer BLAST module indicated that no genes other than *tet*(X3) and *tet*(X4) genes matched the primer sequences designed in this study. Similarly, the results of conventional and real-time PCR also indicated the high specificity of primers and probes (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1Conventional PCR amplification and real-time PCR amplification curve for *tet*(X3) *and te*t(X4) genes. **a--b** were the electrophoresis gel (left) and amplification curve (right) of *tet*(X3) *and tet*(X4). M: Marker. -: negative control. X3 was *tet*(X3) positive strain. X4 was *tet*(X4) positive strain. X, X1, X2 were negative strains

Real-time PCR and standard curve analysis {#Sec4}
-----------------------------------------

Standard curves were obtained using 10-fold serial dilutions of plasmids pTET(X3) and pTET(X4), containing the *tet*(X3) and *tet(*X4) genes to determine the detection limit of the proposed method. The detection range of copies was 1.49 × 10^2^--1.49 × 10^10^ copies/μL for *tet*(X3) and 1.23 × 10^2^--1.23 × 10^10^ copies/μL for *tet*(X4*)*, and cycle threshold (CT) ranges were 37.435--9.663 for *tet*(X3) and 36.894--9.273 for *tet*(X4).

Linear standard curves for real-time PCR are shown in Fig. [2](#Fig2){ref-type="fig"}. The amplification efficiencies were calculated using the formula *E* = 10^(− 1/slope)^ − 1 \[[@CR10]\]. R^2^ values were 0.995 and 0.999, respectively, and efficiency was 90.58 and 97.12% for the *tet*(X3*)* and *tet*(X4) genes, respectively. The sensitivity of analysis was linear within the dynamic range of 9 dilutions. These results reveal that these two real-time PCR tests are accurate for quantitative detection of *tet*(X3) and *tet*(X4) genes. Fig. 2Real-time PCR amplification curves and standard curves. **a--b** Show real-time PCR amplification curves and standard curves *tet*(X3) and *tet*(X4)

Specificity and sensitivity evaluation {#Sec5}
--------------------------------------

To confirm the specificity of the assay, two *E. coli* DH5α strains carrying *tet*(X3) or *tet*(X4) were used as the positive control, while *E. coli* ATCC25922 and three *E. coli* DH5α strains containing *tet*(X), *tet*(X1) or *tet*(X2), respectively, were used as the negative control. Each sample was tested three times independently (*n* = 3). The results of TaqMan-based real-time PCR were 100% concordance with the results of conventional PCR (Table [1](#Tab1){ref-type="table"}**&** Fig. [1](#Fig1){ref-type="fig"}), which proved that the two primer sets and probes were highly specific for their target gene. Table 1Detection of *tet*(X3) and *tet*(X4) genes in isolatesIsolateOriginSpeciesGeneGene LocationReal-time PCR for *tet(X)tet*(X3)*tet*(X4)Ct ± SDATCC25922--*E. coli*--------UndeterminedDH5α-*tet*(X)--*E. colitet*(X)Plasmid----UndeterminedDH5α-*tet*(X1)--*E. colitet*(X1)Plasmid----UndeterminedDH5α-*tet*(X2)--*E. colitet*(X2)Plasmid----UndeterminedDH5α-*tet(X3)*--*E. colitet*(X3)Plasmid+--9.66 ± 0.00DH5α-*tet(X4)*--*E. colitet*(X4)Plasmid--+9.27 ± 0.00CB13Chicken*E. colitet*(X3)Plasmid+--19.05 ± 0.05CB14Chicken*E. colitet*(X3)Plasmid+--21.06 ± 0.08CB15Chicken*E. colitet*(X3)Plasmid+--19.24 ± 0.10CB42Chicken*E. colitet*(X3)Plasmid+--19.24 ± 0.16DZ47Chicken*E. colitet*(X4)Plasmid--+21.90 ± 0.12AZ28Chicken*E. colitet*(X4)Plasmid--+14.79 ± 0.01DZ4RChicken*A. baumanniitet*(X4)Plasmid--+13.42 ± 0.07NM4Chicken*A. baumanniitet*(X4)Plasmid--+14.23 ± 0.13DZ27Chicken*E. colitet*(X4)Plasmid--+17.76 ± 0.13DZ24Chicken*E. colitet*(X4)Plasmid--+14.35 ± 0.10DZ65Chicken*A. baumanniitet*(X4)Plasmid--+21.05 ± 0.05DZ24Chicken*E. colitet*(X4)Plasmid--+18.33 ± 0.09

To further validate the method, genetic DNA extracted from bacteria, faeces and soil samples (three independent technical replicates) was selected to conduct the real-time PCR assay for screening. In this study, some *E. coli* and *A. baumannii* isolates of animal origin were selected for verification, including 4 *tet*(X3) positive strains and 8 *tet*(X4) positive strains (Table [1](#Tab1){ref-type="table"}). The CT ranges were 19.05--21.06, 13.42--21.05 for *tet*(X3), *tet*(X4) genes (Table [1](#Tab1){ref-type="table"}). The results of real-time PCR and previous sequencing analyses were completely consistent, showing high specificity of the method. Moreover, a total of 24 faeces and soil samples from chickens, pigs, and cattle were collected for further evaluation. We were able to detect the two genes in metagenomes extracted from 19 faeces and soil samples, and the relative abundance was normalized using 16S rRNA (gene copies/10^6^ copies of the 16S rRNA gene) \[[@CR11], [@CR12]\]. The real-time PCR assay showed that the normalized copies range from 10^1^ to 10^5^ for genes *tet*(X3) and *tet*(X4) (Fig. [3](#Fig3){ref-type="fig"}). Fig. 3Detection of *tet*(X3) and *tet*(X4) genes in faeces and soil samples. The relative abundance of *tet*(X3) and *tet*(X4) genes (copies /per 1,000,000 copies of 16S rRNA) in the soil and faeces samples

Discussion {#Sec6}
==========

Since the first discovery of the *tet*(X3) and *tet*(X4) genes, these two plasmid-mediated tigecycline resistance genes have been widely reported, suggesting that they are spreading at an alarming rate. It is noteworthy that the *tet*(X3) and *tet*(X4) genes have been identified not only in humans and animals, but also in the environment \[[@CR4], [@CR13], [@CR14]\]. There is a pressing need to establish a fast screening assay for tigecycline resistance genes. So far, there are three reports of fast screening of *tet*(X3) and *tet*(X4), multiplex PCR methods, tetracycline inactivation method, and SYBR Green based real-time PCR, all three methods have approved the effectiveness of methods \[[@CR15]--[@CR17]\]. Compared to traditional detection methods, like conventional PCR and phenotypic method, real-time PCR assays are more sensitive, specific, time-efficient, and labour-saving \[[@CR18]\]. Besides, real-time PCR methods can detect genes in different type of samples other than bacteria. Lately, Fu et al. reported a SYBR Green-based real-time PCR assay for rapid detection of *tet*(X) variants, with a detection limit range from 10^2^ to 10^5^, 1--10^3^ per 10^6^ copies of 16S rRNA for *tet*(X3) and *tet*(X4), respectively. To date, the method based on real-time PCR using TaqMan probe has not been previously proposed.

In this study, we developed a TaqMan-based multiplex real-time PCR assay for the detection of the *tet*(X3) and *tet*(X4) genes. Both *tet*(X3) and *tet*(X4) genes have been successfully identified not only in bacteria isolates, but also directly from faeces and soil samples, with a minimum of 1 copy per 10^5^ copies of 16S rRNA and a maximum of 10^4^ copies per 10^5^ copies of 16S rRNA. Besides, we used constructed *E. coli* DH5α-*tet*(X) strains as positive control and bacteria isolates of animal origin to evaluate the specificity of the method. The *E. coli* ATCC25922 was used as negative control. In our method, only specific amplicons can be bonded by TaqMan probes, which is different from the SYBR-Green dye. The SYBR-Green can bind any double strand DNA fragments in the PCR reaction without any specificity, so melting curve analysis will be necessary to identify the single peak for the PCR reaction. According to the Fig. [1](#Fig1){ref-type="fig"}, our method has high specificity, whereas other *tet*(X) genes couldn't be amplified. A limitation of the proposed method is that these genes cannot be detected simultaneously in a single reaction. However, there are no reports of the co-existence of these two genes. Because *tet*(X3) and *tet*(X4) genes are usually accompanied with MDR \[[@CR9]\], different combinations of such detection methods are flexible and convenient.

Although tigecycline usage has never been approved in animal husbandry, tetracyclines have been widely used in China and many other countries. The total consumption of tetracyclines reached 13,666 tons in 2018 in China, which may provide ongoing selective pressure for the production of tigecycline resistance genes. Many studies have shown that *tet*(X4) can be captured by a range of mobile elements circulating among bacterial strains \[[@CR4], [@CR6]--[@CR8]\], importantly, with the international trade of food-producing animals and their derivatives, a novel antibacterial mechanism may appear. It is of great importance to monitor and eradicate these genes, especially in countries with high tetracycline consumption.

Conclusion {#Sec7}
==========

Overall, we developed a TaqMan-based multiplex real-time PCR method in this study for the rapid detection of tigecycline resistance genes, *tet*(X3) and *tet*(X4). This assay can be widely applied to all laboratories equipped with a qPCR machine, and the whole process could be completed within an hour. It is highly sensitive and specific, and can detect and quantify *tet*(X3) and *tet*(X4) genes accurately in cultured bacteria isolates, faeces and environmental samples.

Methods {#Sec8}
=======

Bacteria strains and environmental samples {#Sec9}
------------------------------------------

All the *E. coli* and *A. baumannii* strains from animal origin used in this study (Table [1](#Tab1){ref-type="table"}) were collected from three poultry farm in Shandong Province, and were identified by conventional PCR and MALDI-TOF before. Five *tet*(X) variant genes were cloned into the PMD-19 T vector (Takara Bio, Kusatsu, Japan), and then transferred into the DH5α cell, including DH5α-*tet*(X), DH5α-*tet*(X1), DH5α-*tet*(X2), DH5α-*tet*(X3) and DH5α-*tet*(X4) (Table [1](#Tab1){ref-type="table"}). A total of 24 faeces and soil samples collected from chickens, pigs, and cattle farms from Sichuan Province were then used for further evaluation (Fig. [1](#Fig1){ref-type="fig"}).

DNA extraction {#Sec10}
--------------

Bacteria were incubated at 37 °C in Brain Heart Infusion broth with agitation at 200 rpm to achieve enough colonies for DNA extraction. Hipure Bacterial DNA Kit (Magen, Guangdong, China) were used to extract bacterial genome according to the manufacturer's instruction. The DNeasy PowerSoil (Qiagen, Hilden, Germany) was used to extract metagenomic DNA from faeces and soil.

Primer and probe design {#Sec11}
-----------------------

The nucleotide sequences of *tet*(X3) and *tet*(X4) were obtained from GenBank. The specific real-time PCR primers and TaqMan probes for these genes (Tables [2](#Tab2){ref-type="table"} & [3](#Tab3){ref-type="table"}) were designed using Primer Express software (ABI-Applied Biosystems Incorporated, Foster City, CA), and the NCBI Primer-BLAST module (<https://www.ncbi.nlm.nih.gov/> tools/primer-blast/) was used to initially validate their specificity. Then, conventional and real-time PCR were both conducted to evaluate the specificity of primers and probes. Table 2Primers for real-time PCR detection of *tet*(X3) and *tet*(X4) genesPrimerSequence (5′-3′)GeneProduct lengthAccession No.Reference*tet*(X3)-qFCAGGACAGAAACAGCGTTGC*tet*(X3)179 bpMK134375.1This study*tet*(X3)-qRGCAGCATCGCCAATCATTGT*tet*(X4)-qFTTGGGACGAACGCTACAAAG*tet*(X4)181 bpMK134376.1This study*tet*(X4)-qRCATCAACCCGCTGTTTACGCTable 3Probes for detection of *tet*(X3) and *tet*(X4) genesProbeSequence (5′-3′)GeneAccession No.Reference*tet*(X3)-PAAGATTTTCCAAATGGAGTGAAG*tet*(X3)MK134375.1This study*tet*(X4)-PTCGTGTGACATCATCT*tet*(X4)MK134376.1This study

Standard curves and PCR conditions {#Sec12}
----------------------------------

The *tet*(X3) and *tet*(X4) *g*enes were cloned into the pMD19-T vector separately, and then transferred into DH5α cells. Standard curves were established using real-time PCR on a QuantStudio™ 7 Flex Real-Time PCR System (ABI-Applied Biosystems Incorporated, Foster City, CA) using 10-fold serial dilutions of the recombinant plasmid DNA with original concentration of 47 ng/μL and 39.4 ng/μL for *tet*(X3) and *tet*(X4), respectively. Multiplex PCR reactions were performed in a total reaction volume of 20 μL, including 0.4 μL of each primer, 0.4 μL of probe, 0.4 μL of Passive Reference Dye (50×) (TransGen Biotech, Beijing, China), 10 μL of 2× TansStart® Probe qPCR SuperMix (TransGen Biotech, Beijing, China), 1.0 μL of DNA template, and 7.4 μL of ddH~2~O. Each pair of primers and probes were optimized to a final concentration of 0.2 pM. Real-time PCR reaction conditions were as follows: a cycle of 95 °C for 30 s, followed by 40 cycles of 95 °C for 5 s and 55 °C for 30 s.

Specificity and sensitivity tests {#Sec13}
---------------------------------

To evaluate the specificity of the proposed method, DH5α strains containing *tet*(X), *tet*(X1), *tet*(X2), *tet*(X3) and *tet*(X4), respectively, were used to conduct the real-time PCR assay (Table [1](#Tab1){ref-type="table"}). Genomic DNA extracted from bacteria, faeces and soil samples from different origin was then used to further validate the specificity and sensitivity of the method.
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